246
Views
1
CrossRef citations to date
0
Altmetric
Invited Reviews

Pediatric Posterior Infectious Uveitis

, MD, , MDORCID Icon, , MDORCID Icon, , MD & , MD
Pages 1944-1954 | Received 22 Aug 2023, Accepted 11 Nov 2023, Published online: 14 Dec 2023

References

  • Tugal-Tutkun I. Pediatric uveitis. J Ophthalmic Vis Res. 2011;6(4):259–269.
  • Paroli MP, Restivo L, Ottaviani E, Nardella C, Abicca I, Spadea L, et al. Clinical features of infectious uveitis in children referred to a hospital-based eye clinic in Italy. Medicina (Kaunas). November 18, 2022;58(11):1673. doi:10.3390/medicina58111673.
  • Cunningham E, Koehler JE. Ocular bartonelosis. Am J Ophthalmol. 2000;130(3):340–349. doi:10.1016/S0002-9394(00)00573-0.
  • Nelson CA, Saha S. Cat-scratch disease in the United States, 2005–2013. Emerg Infect Dis. October 2016;22(10):1741–1746. doi:10.3201/eid2210.160115.
  • Curi AL, Machado D, Heringer G, Campos WR, Lamas C, Rozental T, et al. Lemos E Cat-scratch disease: ocular manifestations and visual outcome. Int Ophthalmol. October 2010;30(5):553–558. doi:10.1007/s10792-010-9389-5.
  • Koehler JE, Glaser CA, Tappero JW. Rochalimaea henselae infection: a new zoonosis with the domestic cat as reservoir. JAMA. 1994;271(7):531e535. doi:10.1001/jama.1994.03510310061039.
  • Biancardi AL, Curi AL. Cat scratch disease. Ocul Immunol Inflamm. 2014;22(2):148–154. doi:10.3109/09273948.2013.833631.
  • Cunningham ET Jr, McDonald HR, Schatz H, Johnson RN, Ai E, Gilbert Grand M. Inflammatory mass of the optic nerve head associated with systemic Bartonella henselae infection. Arch Opthalmol 1997;115(12):1596–1597.
  • Cohen SM, Davis JL, Gass JDM. Branch retinal arterial occlusions in multifocal retinitis with optic nerve edema. Arch Ophtahlmol. 1995;113(10):1271–1276. doi:10.1001/archopht.1995.01100100059029.
  • Eigher-Moscovich M, Amer R, Oray M, Tabbara, KF, Tugal-Tutkun I, Kramer M. Retinal artery occlusions due to Bartonella henselae infection: a case series. Acta Ophthalmol. 2016;94(5):367–370. doi:10.1111/aos.12932.
  • Solley WA, Marin DF, Newman NJ, King R, Callanan DG, Zacchei T, et al. Cat scratch disease : posterior segment manifestations. Opthalmology. 1999;106(8):1546–1553. doi:10.1016/S0161-6420(99)90452-9.
  • Klotz SA, Ianas V, Elliott SP. Cat-scratch disease. Am Fam Physician. 2011;83(2):152–155. 15.
  • Koutantou M, Kambas K, Makka S, Fournier PE, Raoult D, Angelakis E. Limitations of serological diagnosis of Typical cat scratch disease and recommendations for the diagnostic Procedure. Can J Infect Dis Med Microbiol. March 4, 2023;2023:4222511. doi:10.1155/2023/4222511.
  • Barros S, Andrade G, Cavalcanti C, Nascimento H. Cat scratch disease: not a benign condition. Ocul Immunol Inflamm. 2018;26(7):1115–1122. doi:10.1080/09273948.2017.1327077.
  • Ksiaa I, Abroug N, Mahmoud A, Zina S, Hedayatfar A, Attia S, et al. Update on Bartonella neuroretinitis. J Curr Ophthalmol. 2019;31(3):254–261. doi:10.1016/j.joco.2019.03.005.
  • Habot-Wilmer Z, Trivizki O, Goldestein M, Kesler A, Shulman S, Horowitz J, et al. Cat-scratch disease: ocular manifestations and treatment outcome. Acta Ophthalmol. 2018;96(4):524–532. doi:10.1111/aos.13684.
  • Ahn SJ, Ryoo NK, Woo SJ. Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention. Asia Pac Allergy. 2014;4(3):134–141. doi:10.5415/apallergy.2014.4.3.134. Epub 2014/08/07.
  • Ma G, Holland CV, Wang T. Human toxocariasis. Lancet Infect Dis. 2018;18(1):e14–e24. doi:10.1016/S1473-3099(17)30331-6. Epub 2017/08/07.
  • Winders WT, Menkin-Smith L. Toxocara Canis. Treasure Island, FL: StatPearls; 2023.
  • Liu Y, Zhang Q, Li J, Ji X, Xu Y, Zhao P. Clinical characteristics of pediatric patients with ocular toxocariasis in China. Ophthalmologica. 2016;235(2):97–105. doi:10.1159/000443215. Epub 2016/01/14.
  • Jee D, Kim KS, Lee WK, Kim W, Jeon S. Clinical features of ocular toxocariasis in Adult Korean patients. Ocul Immunol Inflammation. 2016;24(2):207–216. doi:10.3109/09273948.2014.994783. Epub 2015/01/08.
  • Padhi TR, Das S, Sharma S, Rath S, Tripathy D, Panda KG, et al. Ocular parasitoses: a comprehensive review. Surv Ophthalmol. 2017;62(2):161–189. doi:10.1016/j.survophthal.2016.09.005. Epub 2016/10/11.
  • Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16(2):265–272. doi:10.1128/CMR.16.2.265-272.2003. Epub 2003/04/15.
  • Schantz PM, Glickman LT. Toxocaral visceral larva migrans. N Engl J Med. 1978;298(8):436–439. doi:10.1056/NEJM197802232980806. Epub 1978/02/23.
  • Merigueti Y, Giuffrida R, da Silva RC, Kmetiuk LB, Santos APD, Biondo AW, et al. Dog and cat contact as risk factor for human toxocariasis: systematic review and meta-analysis. Front Public Health. 2022;10:854468. doi:10.3389/fpubh.2022.854468. Epub 2022/07/16.
  • Deshayes S, Bonhomme J, de La Blanchardière A., de La Blanchardière A. Neurotoxocariasis: a systematic literature review. Infection. October 2016;44(5):565–574. doi:10.1007/s15010-016-0889-8.
  • Ahn SJ, Woo SJ, Jin Y, Chang YS, Kim TW, Ahn J, et al. Clinical features and course of ocular toxocariasis in adults. PLoS Negl Trop Dis. 2014;8(6):e2938. doi:10.1371/journal.pntd.0002938. Epub 2014/06/13.
  • Despreaux R, Fardeau C, Touhami S, Brasnu E, Champion E, Paris L, et al. Ocular toxocariasis: clinical features and long-term visual outcomes in adult patients. Am J Ophthalmol. 2016;166:162–168. doi:10.1016/j.ajo.2016.03.050. Epub 2016/04/14.
  • Gillespie SH, Dinning WJ, Voller A, Crowcroft NS. The spectrum of ocular toxocariasis. Eye (Lond). 1993;7(Pt 3):415–418. doi:10.1038/eye.1993.82. Epub 1993/01/01.
  • Sahu ES, Pal B, Sharma T, Biswas J. Clinical profile, treatment, and visual outcome of ocular Toxocara in a Tertiary Eye Care Centre. Ocul Immunol Inflammation. 2018;26(5):753–759. doi:10.1080/09273948.2016.1249375. Epub 2016/12/03.
  • Wilkinson CP, Welch RB. Intraocular toxocara. Am J Ophthalmol. 1971;71(4):921–930. doi:10.1016/0002-9394(71)90267-4. Epub 1971/04/01.
  • Stewart JM, Cubillan LD, ET C Jr. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina. December 2005;25(8):1005–1013. doi:10.1097/00006982-200512000-00009.
  • Martinez J, Ivankovich-Escoto G, Wu L. Pediatric ocular toxocariasis in Costa Rica: 1998-2018 experience. Ocul Immunol Inflammation. 2021;29(7–8):1246–1251. doi:10.1080/09273948.2020.1792513. Epub 2020/08/19.
  • Gupta A, Tripathy K. Ocular Toxocariasis. Treasure Island, FL: StatPearls; 2023.
  • Campbell JP, Wilkinson CP. Imaging in the diagnosis and management of ocular toxocariasis. Int Ophthalmol Clin. 2012;52(4):145–153. doi:10.1097/IIO.0b013e318265d58b. Epub 2012/09/08.
  • Choi KD, Choi JH, Choi SY, Jung JH. Toxocara optic neuropathy: clinical features and ocular findings. Int J Ophthalmol. 2018;11(3):520–523. doi:10.18240/ijo.2018.03.26. Epub 2018/03/31.
  • Jeon H, Jeong YH, Choi HY, Lee JE, Byon I, Park SW. Clinical features of Toxocara-seropositive optic neuritis in Korea. Ocul Immunol Inflammation. 2019;27(5):829–835. doi:10.1080/09273948.2018.1449866. Epub 2018/04/14.
  • Arevalo JF, Espinoza JV, Arevalo FA. Ocular toxocariasis. J Pediatric Ophthalmol Strabismus. 2013;50(2):76–86. doi:10.3928/01913913-20120821-01. Epub 2012/09/04.
  • Ahn SJ, Woo SJ, Hyon JY, Park KH. Cataract formation associated with ocular toxocariasis. J Cataract Refractive Surg. 2013;39(6):830–835. doi:10.1016/j.jcrs.2012.12.033. Epub 2013/03/08.
  • de Graaf P, Goricke S, Rodjan F, Galluzzi P, Maeder P, Castelijns JA, et al. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol. 2012;42(1):2–14. doi:10.1007/s00247-011-2201-5. Epub 2011/08/19.
  • Chen Q, Gu J, Jiang R, Zhou M, Chang Q. Role of ultrasound biomicroscopy in diagnosis of ocular toxocariasis. British J Ophthalmol. 2018;102(5):642–646. doi:10.1136/bjophthalmol-2017-310583. Epub 2017/09/21.
  • Li S, Sun L, Liu C, Wang W, Huang S, Zhang T, et al. Clinical features of ocular toxocariasis: a comparison between ultra-wide-field and conventional camera imaging. Eye (Lond). 2021;35(10):2855–2863. doi:10.1038/s41433-020-01332-w. Epub 2020/12/05.
  • Hernanz I, Moll-Udina A, BV L, CA A. Ocular toxocariasis: beyond typical patterns through the new imaging technologies. Ocul Immunol Inflammation. 2021;29(7–8):1252–1258. doi:10.1080/09273948.2020.1793370. Epub 2020/08/25.
  • Guo X, Liu H, Li M, Fan K, Li S, Lei B. Multimodality image analysis in a cohort of patients with atypical juvenile ocular toxocariasis. J Ophthalmol. 2021;2021:4853531. doi:10.1155/2021/4853531. Epub 2021/02/26.
  • Sun L, Huang L, Li S, Lu J, Zheng S, Ding X. Safety and effectiveness of intravitreal dexamethasone implant in patients with ocular toxocariasis. British J Ophthalmol. 2023:bjo-2022–322244. doi:10.1136/bjo-2022-322244. Epub 2023/01/04.
  • Zhang T, Guo D, Xu G, Jiang R. Ocular toxocariasis: long-term follow-up and prognosis of patients following vitrectomy. Ocul Immunol Inflammation. 2020;28(3):517–523. Epub 2019/07/16.
  • Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55(3):173–183. doi:10.4103/0301-4738.31936.
  • Gupta V, Gupta A, Rao NA. Intraocular tuberculosis – an update. Surv Ophthalmol. 2007;52(6):561–587. doi:10.1016/j.survophthal.2007.08.015.
  • Kaur S, Aggarwal K, Agarwal A, Suri D, Gupta A, Singh R, et al. Clinical course and outcomes of pediatric tubercular uveitis in North India. Ocul Immunol Inflamm. 2018;26(6):859–864. doi:10.1080/09273948.2017.1296579.
  • Majumder PD, Sudharshan S, Biswas J. Laboratory support in the diagnosis of uveitis. Indian, J Ophthalmol. June 2013;61(6):269–276. doi:10.4103/0301-4738.114095.PMID:23803478;PMCID:PMC3744779.
  • Lee C, Agrawal R, Pavesio C. Ocular tuberculosis – a clinical conundrum. Ocul Immunol Inflamm. 2016;24(2):237–242. doi:10.3109/09273948.2014.985387.
  • Kee AR, Gonzalez-Lopez JJ, Al-Hity A, Gupta B, Lee CS, Gunasekeran DV, et al. Anti tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis. Surv Ophthalmol. 2016;61(5):628–653. doi:10.1016/j.survophthal.2016.03.001.
  • Li AL, Grant D, Gbakie M, Kanneh L. Ophthalmic manifestations and vision impairment in Lassa fever survivors. PLoS One. December 10, 2020;15(12):e0243766. doi:10.1371/journal.pone.0243766.
  • Chung JW, Engin Ö, Wolfs TFW, Renson TJC, de Boer JH. Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Lancet. April 3, 2021;397(10281):e10. doi:10.1016/S0140-6736(21)00579-1.
  • Kanik-Yuksek S, Gülhan B, Tezer H, Ozkaya-Parlakay A. A perinatal cytomegalovirus infection in an immunocompetent patient with chorioretinitis. J Trop Pediatr. October 2014;60(5):401–403. doi:10.1093/tropej/fmu024.
  • Hettinga YM, de Groot-Mijnes JD, Rothova A, de Boer JH. Infectious involvement in a tertiary center pediatric uveitis cohort. Br J Ophthalmol. January 2015;99(1):103–107. doi:10.1136/bjophthalmol-2014-305367.
  • Islam SM, El-Sheikh HF, Tabbara KF. Anterior uveitis following combined vaccination for measles, mumps and rubella (MMR): a report of two cases. Acta Ophthalmol Scand. October 2000;78(5):590–592. doi:10.1034/j.1600-0420.2000.078005590.x.
  • Testi I, Brandão-de-Resende C, De-La-Torre A, Concha-Del-Rio, LE, Cheja-Kalb R, Mahendradas P, et al. Ocular inflammatory events following COVID-19 vaccination in the paediatric population: a multinational case series. Ocul Immunol Inflamm. June 2023;14:1–6. doi:10.1080/09273948.2023.2220782.
  • Saranappa SBS, Sowbhagya HN. Panophthalmitis in dengue fever. Indian Pediatr. September 2012;49(9):760. doi:10.1007/s13312-012-0142-1.PMID:23024087.
  • Smith JR, Todd S, Ashander LM, Charitou T, Ma Y, Yeh S, et al. Retinal pigment epithelial cells are a potential reservoir for Ebola virus in the human eye. Transl Vis Sci Technol. July 14, 2017;6(4):12. doi:10.1167/tvst.6.4.12.
  • Öztürk C, Yüce Sezen A, Savaş Şen Z, Özdem S. Bilateral acute anterior uveitis and corneal punctate epitheliopathy in children diagnosed with multisystem inflammatory syndrome secondary to COVID-19. Ocul Immunol Inflammation. May 19, 2021;29(4):700–704. doi:10.1080/09273948.2021.1909070.
  • Alnahdi MA, Alkharashi M. Ocular manifestations of COVID-19 in the pediatric age group. Eur J Ophthalmol. January 2023;33(1):21–28. doi:10.1177/11206721221116210.
  • He L, Duan J, Shang Q. Case report: herpes simplex virus type 2 acute retinal necrosis with viral encephalitis in children. Front Med (Lausanne). March 16, 2022;9:815546. doi:10.3389/fmed.2022.815546.
  • Mahendradas P, Sinha S, Vinekar A, Pradeep M, Shetty BK. Bilateral acute necrotizing retinitis due to cytomegalovirus infection in an infant: challenging case report. Am J Ophthalmol Case Rep. September 10, 2019;16:100553. doi:10.1016/j.ajoc.2019.100553.
  • Yavuz Saricay L, Baldwin G, Leake K, Johnston A, Shah AS, Patel NA, et al. Cytomegalovirus retinitis and immune recovery uveitis in a pediatric patient with leukemia. J Aapos. February 2023;27(1):52–55. doi:10.1016/j.jaapos.2022.10.004.
  • Hettinga YM, de Groot-Mijnes JD, Rothova A, de Boer JH. Infectious involvement in a tertiary center pediatric uveitis cohort. Br J Ophthalmol. January, 2015;99(1):103–107. doi:10.1136/bjophthalmol-2014-305367.
  • De Groot-Mijnes JD, Rothova A, Van Loon AM, Schuller M, Ten Dam-Van Loon NH, De Boer JH, et al. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am J Ophthalmol. February 2006;141(2):313–8. doi:10.1016/j.ajo.2005.09.017.
  • Lee JH, Agarwal A, Mahendradas P, Lee CS, Gupta V, Pavesio CE, et al. Viral posterior uveitis. Surv Ophthalmol. July-August, 2017;62(4):404–445. doi:10.1016/j.survophthal.2016.12.008.
  • Lee CT, Hsieh TH, Chu CC, Hsu YR, Wang JH, Wang JK, et al. Hyperbaric oxygen therapy as rescue therapy for pediatric frosted branch angiitis with Purtscher-like retinopathy: a case report. Front Med (Lausanne). April 17, 2023;10:1119623. doi:10.3389/fmed.2023.1119623.
  • Gomez-Marin JE, de-la-Torre A. Chapter 5 - ocular disease due to Toxoplasma gondii. In: Weiss L, Kim K eds. Toxoplasma Gondii. 3rd ed. Academic Press; 2020:229–291. doi:10.1016/B978-0-12-815041-2.00005-0
  • Toxoplasma Gondii. Elsevier; 2020. doi:10.1016/C2017-0-01845-1.
  • Petersen E, Kijlstra A, Stanford M. Epidemiology of ocular toxoplasmosis. Ocul Immunol Inflammation. 2012;20(2):68–75. doi:10.3109/09273948.2012.661115.
  • Coutinho SG, Leite MA, Amendoeira MR, Marzochi MC. Concomitant cases of acquired toxoplasmosis in children of a single family: evidence of reinfection. J Infect Dis. 1982;146(1):30–33. doi:10.1093/infdis/146.1.30.
  • Brynska A, Tomaszewicz-Libudzic E, Wolanczyk T. Obsessive-compulsive disorder and acquired toxoplasmosis in two children. Eur Child Adolesc Psychiatry. 2001;10(3):200–204. doi:10.1007/s007870170027.
  • Williams M, Savage DC. Acquired toxoplasmosis in children. Arch Dis Child. 1978;53(10):829–829. doi:10.1136/adc.53.10.829.
  • McNicholl B, Flynn J. Acquired toxoplasmosis in children. Arch Dis Child. 1978;53(5):414–416. doi:10.1136/adc.53.5.414.
  • Rand AJ, Buck AB, Love PB, Prose NS, Selim MA. Cutaneous acquired toxoplasmosis in a child: a case report and review of the literature. Am J Dermatopathol. 2015;37(4):305310. doi:10.1097/DAD.0000000000000072.
  • Neumann CG. Acquired toxoplasmosis in a child. Arch Pediatr Adolesc Med. 1960;100(1):117. doi:10.1001/archpedi.1960.04020040119017.
  • Dubey JP. Sources of Toxoplasma gondii infection in pregnancy. BMJ. 2000;321(7254):127–128. doi:10.1136/bmj.321.7254.127.
  • Dubey JP, Beattie CP. Toxoplasmosis of animals and man. Toxoplasmosis of animals and man. Published online 1988. https://www.cabdirect.org/cabdirect/abstract/19892292620. Accessed August10, 2023.
  • Garweg JG, Scherrer J, Wallon M, Kodjikian L, Peyron F. Reactivation of ocular toxoplasmosis during pregnancy. BJOG: Int J Obstet Gynaecol. 2005;112(2):241–242. doi:10.1111/j.1471-0528.2004.00302.x.
  • Andrade GMQ, Vasconcelos-Santos DV, Carellos EVM, Romanelli RMC, Vitor RWA, Carneiro ACAV, et al. Congenital toxoplasmosis from a chronically infected woman with reactivation of retinochoroiditis during pregnancy – an underestimated event? J Pediatr (Rio J). 2009. doi:10.2223/JPED.1948.
  • Silveira C, Ferreira R, Muccioli C, Nussenblatt R, Belfort R. Toxoplamosis transmitted to a newborn from the mother infected 20 years earlier. Am J Ophthalmol. 2003;136(2):370–371. doi:10.1016/S0002-9394(03)00191-0.
  • Kodjikian L, Hoigne I, Adam O, Jacquier P, Aebi-Ochsner C, Aebi C, et al. Vertical transmission of toxoplasmosis from a chronically infected immunocompetent woman. J Pediatr Infect. 2004;23(3):272–274. doi:10.1097/01.inf.0000115949.12206.69.
  • Vutova K, Peicheva Z, Popova A, Markova V, Mincheva N, Todorov T. Congenital toxoplasmosis: eye manifestations in infants and children. Ann Trop Paediatr. 2002;22(3):213–218. doi:10.1179/027249302125001507.
  • Gómez-Marin JE, de-la-Torre A, Angel-Muller E, Rubio J, Arenas J, Osorio E, et al. First Colombian multicentric newborn screening for congenital Toxoplasmosis. Cappello M, ed. PLoS Negl Trop Dis. 2011;5(5):e1195. doi:10.1371/journal.pntd.0001195.
  • Dubey JP, Murata FHA, Cerqueira-Cézar CK, Kwok OCH, Villena I. Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections. Parasitology. 2021;148(12):1406–1416. doi:10.1017/S0031182021001013.
  • The SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet. 2007;369(9556):115–122. doi:10.1016/S0140-6736(07)60072-5.
  • Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LMG, Tan HK, Wallon M, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2(8):e277. doi:10.1371/journal.pntd.0000277.
  • Sauer A, de la Torre A, Gomez-Marin J, Bourcier T, Garweg J, Speeg-Schatz C, et al. Prevention of retinochoroiditis in congenital toxoplasmosis: Europe versus South America. J Pediatr Infect. 2011;30(7):601. doi:10.1097/INF.0b013e3182129e70.
  • Holec-Gąsior L, Sołowińska K. IgG avidity test as a tool for discrimination between recent and distant Toxoplasma gondii infection—current status of studies. Antibodies. 2022;11(3):52. doi:10.3390/antib11030052.
  • Villard O, Cimon B, L’Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, et al. Serological diagnosis of Toxoplasma gondii infection. Diagn Microbiol Infect Dis. 2016;84(1):22–33. doi:10.1016/j.diagmicrobio.2015.09.009.
  • Vidigal PVT, Santos DVV, Castro FC, Couto JCDF, Vitor RWDA, Brasileiro Filho G. Prenatal toxoplasmosis diagnosis from amniotic fluid by PCR. Rev Soc Bras Med Trop. 2002;35(1):1–6. doi:10.1590/S0037-86822002000100001.
  • Freeman K, Tan HK, Prusa A, Petersen E, Buffolano W, Malm G, et al. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics. 2008;121(5):e1215–e1222. doi:10.1542/peds.2007-2169.
  • Codaccioni C, Picone O, Lambert V, Maurice P, Pomar L, Winer N, et al. Ultrasound features of fetal toxoplasmosis: a contemporary multicenter survey in 88 fetuses. Prenat Diagn. 2020;40(13):1741–1752. doi:10.1002/pd.5756.
  • Estrada M, De La Torre A, Gómez-Marín JE. Diagnóstico prenatal ecográfico de catarata en un caso de toxoplasmosis congénita, Quindio (Colombia). Rev Colomb Obstet Ginecol. 2010;61(3):267–272. doi:10.18597/rcog.274.
  • Lazarte-Rantes C, Rodríguez-Anccasi R, Rivas-Campos C, Silva E. Congenital toxoplasmosis: findings in fetal MRI. Cureus. Published online August 4, 2021. doi:10.7759/cureus.16894.
  • Chan NSW, Choi J, Cheung CMG. Pediatric Uveitis. Asia-Pac J Ophthalmol. 2018;7(3):192. doi:10.22608/APO.2018116.
  • Lebech M, Joynson DHM, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, et al. Classification system and case definitions ofToxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis. 1996;15(10):799–805. doi:10.1007/BF01701522.
  • Kalogeropoulos D, Sakkas H, Mohammed B, Vartholomatos G, Malamos K, Sreekantam S, et al. Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int Ophthalmol. 2022;42(1):295–321. doi:10.1007/s10792-021-01994-9.
  • Lonngi M, Aguilar MC, Ríos HA, Aristizábal-Duque CH, Rodríguez FJ, de-la-Torre A. Pediatric uveitis: experience in Colombia. Ocul Immunol Inflammation. 2016;24(4):410–414. doi:10.3109/09273948.2016.1160129.
  • Maleki A, Anesi SD, Look-Why S, Manhapra A, Foster CS. Pediatric uveitis: a comprehensive review. Surv Ophthalmol. 2022;67(2):510–529. doi:10.1016/j.survophthal.2021.06.006.
  • Zuluaga C, Sierra MV, Asprilla E. Causas de ceguera infantil en Cali, Colombia. Colombia Medica. 2005;36(4):235–238. https://colombiamedica.univalle.edu.co/index.php/comedica/article/view/382. Accessed August 10, 2023.
  • Lago EG, Endres MM, MFDC S, Fiori HH. Ocular outcome of Brazilian patients with congenital toxoplasmosis. J Pediatr Infect. 2021;40(1):e21–e27. doi:10.1097/INF.0000000000002931.
  • Wallon M, Garweg JG, Abrahamowicz M, Cornu C, Vinault S, Quantin C, et al. Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence. Pediatrics. 2014;133(3):e601–e608. doi:10.1542/peds.2013-2153.
  • Kodjikian L, Wallon M, Fleury J, Denis P, Binquet C, Peyron F, et al. Ocular manifestations in congenital toxoplasmosis. Graefe’s Arch Clin Exp Ophthalmo. 2006;244(1):14–21. doi:10.1007/s00417-005-1164-3.
  • Tan HK, Schmidt D, Stanford M, Teär-Fahnehjelm K, Ferret N, Salt A, et al. Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis. Am J Ophthalmol. 2007;144(5):648–653.e2. doi:10.1016/j.ajo.2007.07.013.
  • Balasundaram MB. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol. 2010;128(1):28. doi:10.1001/archophthalmol.2009.354.
  • Delair E, Monnet D, Grabar S, Dupouy-Camet J, Yera H, Brézin AP. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis. Am J Ophthalmol. 2008;146(6):851–855. doi:10.1016/j.ajo.2008.06.027.
  • Suhardjo N, Utomo PT, Agni AN. Clinical manifestations of ocular toxoplasmosis in Yogyakarta, Indonesia: a clinical review of 173 cases. Southeast Asian J Trop Med Public Health. 2003;34:291–297.
  • Park YH, Nam HW. Clinical features and treatment of ocular toxoplasmosis. Korean J Parasitol. 2013;51(4):393–399. doi:10.3347/kjp.2013.51.4.393.
  • Khan S. Ocular manifestations of the antineutrophil cytoplasmic antibody and antiphospholipid syndromes. Indian J Ophthalmol. 2013;61(7):365–366. doi:10.4103/0301-4738.111127.
  • Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. Fisk NM, ed. PLoS Med. 2010;7(10):e1000351. doi:10.1371/journal.pmed.1000351.
  • Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy. Cochrane Pregnancy and Childbirth Group, ed. Cochrane Database Syst Rev. 1999;2010(1). doi:10.1002/14651858.CD001684.
  • Paquet C, Yudin MH, Society of Obstetricians and Gynaecologists of Canada. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can. 2013;35(1):78–79. doi:10.1016/S1701-2163(15)31053-7.
  • Peyron F, L’ollivier C, Mandelbrot L, Wallon M, Piarroux R, Kieffer F, et al. Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French multidisciplinary working group. Pathogens. 2019;8(1):24. doi:10.3390/pathogens8010024.
  • Montoya JG, Remington JS. Clinical practice: management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008;47(4):554–566. doi:10.1086/590149.
  • McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz. 2009;104(2):320–344. doi:10.1590/S0074-02762009000200029.
  • Berrébi A, Assouline C, Bessières MH, Lathière M, Cassaing S, Minville V, et al. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol. 2010;203(6):.e552.1–.e552.6. doi:10.1016/j.ajog.2010.06.002.
  • Cifuentes-González C, Rojas-Carabali W, Pérez ÁO, Carvalho É, Valenzuela F, Miguel-Escuder L, et al. Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: a systematic review and meta-analysis. Hwang DK, ed. PLoS One. 2023;18(4):e0283845. doi:10.1371/journal.pone.0283845.
  • Phan L, Kasza K, Jalbrzikowski J, Gwendolyn Noble A, Latkany P, Kuo A, et al. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol. 2008;146(3):375–384.e4. doi:10.1016/j.ajo.2008.04.033.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.